76 research outputs found

    Machine Learning-Enabled IoT Security: Open Issues and Challenges Under Advanced Persistent Threats

    Full text link
    Despite its technological benefits, Internet of Things (IoT) has cyber weaknesses due to the vulnerabilities in the wireless medium. Machine learning (ML)-based methods are widely used against cyber threats in IoT networks with promising performance. Advanced persistent threat (APT) is prominent for cybercriminals to compromise networks, and it is crucial to long-term and harmful characteristics. However, it is difficult to apply ML-based approaches to identify APT attacks to obtain a promising detection performance due to an extremely small percentage among normal traffic. There are limited surveys to fully investigate APT attacks in IoT networks due to the lack of public datasets with all types of APT attacks. It is worth to bridge the state-of-the-art in network attack detection with APT attack detection in a comprehensive review article. This survey article reviews the security challenges in IoT networks and presents the well-known attacks, APT attacks, and threat models in IoT systems. Meanwhile, signature-based, anomaly-based, and hybrid intrusion detection systems are summarized for IoT networks. The article highlights statistical insights regarding frequently applied ML-based methods against network intrusion alongside the number of attacks types detected. Finally, open issues and challenges for common network intrusion and APT attacks are presented for future research.Comment: ACM Computing Surveys, 2022, 35 pages, 10 Figures, 8 Table

    Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Celastrol is an active ingredient of the traditional Chinese medicinal plant <it>Tripterygium Wilfordii</it>, which exhibits significant antitumor activity in different cancer models <it>in vitro </it>and <it>in vivo</it>; however, the lack of information on the target and mechanism of action of this compound have impeded its clinical application. In this study, we sought to determine the mode of action of celastrol by focusing on the processes that mediate its anticancer activity.</p> <p>Methods</p> <p>The downregulation of heat shock protein 90 (HSP90) client proteins, phosphorylation of c-Jun NH2-terminal kinase (JNK), and cleavage of PARP, caspase 9 and caspase 3 were detected by western blotting. The accumulation of reactive oxygen species (ROS) was analyzed by flow cytometry and fluorescence microscopy. Cell cycle progression, mitochondrial membrane potential (MMP) and apoptosis were determined by flow cytometry. Absorption spectroscopy was used to determine the activity of mitochondrial respiratory chain (MRC) complexes.</p> <p>Results</p> <p>Celastrol induced ROS accumulation, G2-M phase blockage, apoptosis and necrosis in H1299 and HepG2 cells in a dose-dependent manner. N-acetylcysteine (NAC), an antioxidative agent, inhibited celastrol-induced ROS accumulation and cytotoxicity. JNK phosphorylation induced by celastrol was suppressed by NAC and JNK inhibitor SP600125 (SP). Moreover, SP significantly inhibited celastrol-induced loss of MMP, cleavage of PARP, caspase 9 and caspase 3, mitochondrial translocation of Bad, cytoplasmic release of cytochrome c, and cell death. However, SP did not inhibit celastrol-induced ROS accumulation. Celastrol downregulated HSP90 client proteins but did not disrupt the interaction between HSP90 and cdc37. NAC completely inhibited celastrol-induced decrease of HSP90 client proteins, catalase and thioredoxin. The activity of MRC complex I was completely inhibited in H1299 cells treated with 6 μM celastrol in the absence and presence of NAC. Moreover, the inhibition of MRC complex I activity preceded ROS accumulation in H1299 cells after celastrol treatment.</p> <p>Conclusion</p> <p>We identified ROS as the key intermediate for celastrol-induced cytotoxicity. JNK was activated by celastrol-induced ROS accumulation and then initiated mitochondrial-mediated apoptosis. Celastrol induced the downregulation of HSP90 client proteins through ROS accumulation and facilitated ROS accumulation by inhibiting MRC complex I activity. These results identify a novel target for celastrol-induced anticancer activity and define its mode of action.</p

    Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The JAK2<sup>V617F </sup>mutation plays a major role in the pathogenesis of myeloproliferative neoplasms and is found in the vast majority of patients suffering from polycythemia vera and in roughly every second patient suffering from essential thrombocythemia or from primary myelofibrosis. The V617F mutation is thought to provide hematopoietic stem cells and myeloid progenitors with a survival and proliferation advantage. It has previously been shown that activated JAK2 promotes cell survival by upregulating the anti-apoptotic STAT5 target gene Bcl-xL. In this study, we have investigated the role of additional apoptotic players, the pro-apoptotic protein Bim as well as the anti-apoptotic protein Mcl-1.</p> <p>Methods</p> <p>Pharmacological inhibition of JAK2/STAT5 signaling in JAK2<sup>V617F </sup>mutant SET-2 and MB-02 cells was used to study effects on signaling, cell proliferation and apoptosis by Western blot analysis, WST-1 proliferation assays and flow cytometry. Cells were transfected with siRNA oligos to deplete candidate pro- and anti-apoptotic proteins. Co-immunoprecipitation assays were performed to assess the impact of JAK2 inhibition on complexes of pro- and anti-apoptotic proteins.</p> <p>Results</p> <p>Treatment of JAK2<sup>V617F </sup>mutant cell lines with a JAK2 inhibitor was found to trigger Bim activation. Furthermore, Bim depletion by RNAi suppressed JAK2 inhibitor-induced cell death. Bim activation following JAK2 inhibition led to enhanced sequestration of Mcl-1, besides Bcl-xL. Importantly, Mcl-1 depletion by RNAi was sufficient to compromise JAK2<sup>V617F </sup>mutant cell viability and sensitized the cells to JAK2 inhibition.</p> <p>Conclusions</p> <p>We conclude that Bim and Mcl-1 have key opposing roles in regulating JAK2<sup>V617F </sup>cell survival and propose that inactivation of aberrant JAK2 signaling leads to changes in Bim complexes that trigger cell death. Thus, further preclinical evaluation of combinations of JAK2 inhibitors with Bcl-2 family antagonists that also tackle Mcl-1, besides Bcl-xL, is warranted to assess the therapeutic potential for the treatment of chronic myeloproliferative neoplasms.</p

    Fossil plant remains in DSDP Leg 80 holes

    No full text
    The lower part of the syn-rift Barremian-?Hauterivian section at Site 549 contains a large amount of acid-resistant land-derived organic matter that, as elsewhere in the Cretaceous sediments of the IPOD Leg 80 sites, is thermally immature. This plant debris was derived from a vegetation made up of many species of pteridophytes and gymnosperms. The palynofacies indicate that the sediments were deposited in shallow marginal and nonmarine environments and that the climate was probably warm temperate and fairly moist at the time. Source potential for gas is suggested at some horizons. Most of the younger Lower Cretaceous sediments at this and the other sites were deposited in more open marine conditions. Although they generally contain less organic matter, land plant remains continue to comprise a major part of the palynofacies. The Upper Cretaceous sediments were mainly deposited in well oxygenated conditions and are organically lean. However, stratigraphically restricted dark-colored shales at Sites 549 to 551 contain relatively large quantities of amorphous detritus of at least partly marine origin. These characteristics are suggestive of deposition during periods of restricted circulation and also of source potential for oil and gas if maturation levels had been higher
    corecore